CERo Therapeutics Holdings, Inc. , an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
Cero Therapeutics Holdings stock last closed at $0.89, down 6.12% from the previous day, and has decreased 99.36% in one year. It has underperformed other stocks in the Biotechnology industry by 0.22 percentage points. Cero Therapeutics Holdings stock is currently +66.67% from its 52-week low of $0.53, and -99.38% from its 52-week high of $143.00.
As of Apr 30, 2025, there are 5.38M shares of CERO outstanding. The market cap of CERO is $4.79M. In the past 24 hours, 298,708 CERO shares were traded.
How to Buy Cero Therapeutics Holdings Stock
Not sure how to invest in Cero Therapeutics Holdings stock? Here's how.
Figure out where to buy Cero Therapeutics Holdings stock: You need to pick an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you choose where to buy Cero Therapeutics Holdings stock.
Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Put funds into your investment account: Select your payment method and add your details.
Analyze Cero Therapeutics Holdings stock: The Cero Therapeutics Holdings ticker symbol is CERO. Is Cero Therapeutics Holdings stock a good investment? Should you buy shares of CERO? How do CERO's underlying business fundamentals look? Do top analysts think Cero Therapeutics Holdings is a good buy? Why has CERO's stock price moved recently? (Hint: Our stock market analysis website can help you decide if CERO is a good stock to buy).
Place your CERO buy order: Decide if you will purchase CERO shares at the current market price or use a limit order to purchase CERO shares at a particular price.
Monitor your investment in CERO: Create a watchlist to get live updates on your position in Cero Therapeutics Holdings stock.
Step 1: Figure out where to buy Cero Therapeutics Holdings stock
You need an online brokerage account to access the NASDAQ market and buy CERO stock.
A brokerage account allows you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our research, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world markets: From Tech to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to invest in CERO stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Cero Therapeutics Holdings stock
Once you have identified the best place to buy Cero Therapeutics Holdings stock, it's crucial to research their stock before you invest, so you can comprehend the risk and upside.
Cero Therapeutics Holdings shares data
CERO Price
$0.89
1w %
11.39%
1y %
-99.36%
5y %
N/A
P/E
-0.05x
P/B
-2.53x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$10.52M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$4.79M
Next Earnings
N/A
Next Dividend
N/A
CERO Overview
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis in less time.
Over the past 12 months, insiders at CERO have sold more shares than they have bought.
Yk Bioventures Opportunities GP I LLC, 10% Owner of CERO, was the latest CERO insider to sell. They sold $179,934.48 worth of CERO shares on Dec 13, 2024.
No, Cero Therapeutics Holdings doesn't provide an income stream by paying out dividends.
CERO Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your CERO buy order
You have two main types of orders:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are usually fine.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at an exact price limit, place a limit order.
Click the Open button and your broker will place your order.
If you require additional help with investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Cero Therapeutics Holdings share?
As of Apr 30, 2025, it costs $0.89 to buy one share of Cero Therapeutics Holdings stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.45, you can buy 0.5 shares of CERO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.